Jeffrey F. Waring

ORCID: 0000-0002-7769-0367
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Gene expression and cancer classification
  • Alzheimer's disease research and treatments
  • Epigenetics and DNA Methylation
  • Computational Drug Discovery Methods
  • Bioinformatics and Genomic Networks
  • Genetic Associations and Epidemiology
  • Cytokine Signaling Pathways and Interactions
  • Dementia and Cognitive Impairment Research
  • Protein Tyrosine Phosphatases
  • Pharmacogenetics and Drug Metabolism
  • Drug Transport and Resistance Mechanisms
  • Molecular Biology Techniques and Applications
  • Drug-Induced Hepatotoxicity and Protection
  • Hepatitis C virus research
  • Chronic Lymphocytic Leukemia Research
  • Nicotinic Acetylcholine Receptors Study
  • Receptor Mechanisms and Signaling
  • Cholinesterase and Neurodegenerative Diseases
  • interferon and immune responses
  • Acute Myeloid Leukemia Research
  • HIV Research and Treatment
  • Neuroscience and Neuropharmacology Research
  • HIV/AIDS drug development and treatment
  • Metabolism, Diabetes, and Cancer
  • Genomics and Rare Diseases

AbbVie (United States)
2015-2024

Abbott Fund
2003-2012

Abbott (United States)
2002-2012

Abbott (United Kingdom)
2006-2011

Children's Hospital of Eastern Ontario
2008

Cleveland Clinic
2007

Michigan State University
2005-2006

University of Minnesota System
2001

Institute of Human Genetics
2001

Cancer Research UK Manchester Institute
1999

The cellular inhibitor of apoptosis 1 and 2 (cIAP1 cIAP2) proteins have been implicated in the activation NF-kappaB by TNFalpha; however, genetic deletion either cIAP1 or did not support a physiologically relevant role, perhaps because functional redundancy. To address this, we used combined siRNA knockdown approaches report that are indeed critical, yet redundant, regulators upon TNFalpha treatment. Whereas was properly activated cultured primary cells deficient 2, removal both cIAPs...

10.1073/pnas.0711122105 article EN Proceedings of the National Academy of Sciences 2008-08-13

The role of protein-tyrosine phosphatase 1B (PTP1B) in diabetes was investigated using an antisense oligonucleotide ob / and db mice. PTP1B treatment normalized plasma glucose levels, postprandial excursion, HbA 1C . Hyperinsulinemia also reduced with improved insulin sensitivity. protein mRNA were liver fat no effect skeletal muscle. Insulin signaling proteins, receptor substrate 2 phosphatidylinositol 3 (PI3)-kinase regulatory subunit p50α, increased PI3-kinase p85α expression decreased...

10.1073/pnas.142298199 article EN Proceedings of the National Academy of Sciences 2002-08-08
Rubina Tabassum Joel Rämö Pietari Ripatti Jukka Koskela Mitja Kurki and 95 more Juha Karjalainen Priit Palta Shabbeer Hassan Javier Núñez-Fontarnau Tuomo Kiiskinen Sanni Söderlund Niina Matikainen Mathias J. Gerl Michał A. Surma Christian Klose Nathan O. Stitziel Hannele Laivuori Aki S. Havulinna Susan K. Service Veikko Salomaa Matti Pirinen Anu Jalanko Jaakko Kaprio Kati Donner Mari Kaunisto Nina Mars Alexander Dada Anastasia Shcherban Andrea Ganna Arto Lehistö Elina Kilpeläinen Georg Brein Awaisa Ghazal Jarmo Harju Kalle Pärn Pietro Della Briotta Parolo Risto Kajanne Susanna Lemmelä Timo P. Sipilä Tuomas Sipilä Ulrike Lyhs Vincent Llorens Teemu Niiranen Kati Kristiansson Lotta Männikkö Manuel González Jiménez Markus Perola Regis Wong Terhi Kilpi Tero Hiekkalinna Elina Järvensivu Essi Kaiharju Hannele Mattsson Markku Laukkanen Päivi Laiho Sini Lähteenmäki Tuuli Sistonen Sirpa Soini Adam Ziemann Anne Lehtonen Apinya Lertratanakul Bob Georgantas Bridget Riley‐Gillis Danjuma Quarless Fedik Rahimov Graham Heap Howard J. Jacob Jeffrey F. Waring J. Wade Davis Nizar Smaoui Relja Popovic Sahar Esmaeeli Jeff Waring Athena Matakidou Ben Challis David A. Close Slavé Petrovski Antti Karlsson Johanna Schleutker Kari Pulkki Petri Virolainen Lila Kallio Graham J. Mann Sami Heikkinen Veli‐Matti Kosma Chia‐Yen Chen Heiko Runz Jiang Liu Paola G. Bronson Sally John Sanni Lahdenperä Susan Eaton Wei Zhou Minna Hendolin Outi Tuovila Raimo Pakkanen Joseph Maranville Keith Usiskin Marla Hochfeld Robert Plenge

Abstract Understanding genetic architecture of plasma lipidome could provide better insights into lipid metabolism and its link to cardiovascular diseases (CVDs). Here, we perform genome-wide association analyses 141 species (n = 2,181 individuals), followed by phenome-wide scans with 25 CVD related phenotypes 511,700 individuals). We identify 35 lipid-species-associated loci (P <5 ×10 −8 ), 10 which associate risk including five new loci- COL5A1 , GLTPD2 SPTLC3 MBOAT7 GALNT16 (false...

10.1038/s41467-019-11954-8 article EN cc-by Nature Communications 2019-09-24
Jaakko Tyrmi Tea Kaartokallio A. Inkeri Lokki Tiina Jääskeläinen Eija Kortelainen and 95 more Sanni Ruotsalainen Juha Karjalainen Samuli Ripatti Anna Kivioja Triin Laisk Johannes Kettunen Anneli Pouta Katja Kivinen Eero Kajantie Seppo Heinonen Juha Kere Hannele Laivuori Eeva Ekholm Reija Hietala-Koivu Leea Keski‐Nisula Kaarin Mäkikallio Jukka Uotila Susanna Sainio Terhi Saisto Marja Vääräsmäki Tia Aalto-Viljakainen Leena Georgiadis Jenni Heikkinen‐Eloranta Miira M. Klemetti Sanna Suomalainen‐König Satu Wedenoja Satu Leminen Aija Lähdesmäki Susanna Mehtälä Christina Salmén Aarno Palotie Mark J. Daly Bridget Riley-Gills Howard J. Jacob Dirk S. Paul Athena Matakidou Adam Platt Heiko Runz Sally John George Okafo Nathan Lawless Robert M. Plenge Joseph Maranville Mark I. McCarthy Julie Hunkapiller Margaret G. Ehm Kirsi Auro Simonne Longerich Caroline S. Fox Anders Mälarstig K. Klinger Deepak Raipal Eric Green Robert Graham Robert Yang Chris O ́Donnell Tomi P. Mäkelä Jaakko Kaprio Petri Virolainen Antti Hakanen Terhi Kilpi Markus Perola Jukka Partanen Anne Pitkäranta Juhani Junttila Raisa Serpi Tarja Laitinen Veli‐Matti Kosma Jari A. Laukkanen Marco Hautalahti Outi Tuovila Raimo Pakkanen Jeffrey F. Waring Bridget Riley‐Gillis Fedik Rahimov Ioanna Tachmazidou Chia‐Yen Chen Zhihao Ding Marc Jung Shameek Biswas Rion Pendergrass David Pulford Neha Raghavan Adriana Huertas‐Vázquez Jae-Hoon Sul Xinli Hu Sahar V. Mozaffari Dawn Waterworth Nicole Renaud Ma ́en Obeidat Johanna Schleutker Mikko Arvas Olli Carpén Reetta Hinttala Graham J. Mann

A genetic contribution to preeclampsia susceptibility has been established but is still incompletely understood.To disentangle the underlying architecture of and or other maternal hypertension during pregnancy with a genome-wide association study (GWAS) hypertensive disorders pregnancy.This GWAS included meta-analyses in combination phenotype encompassing disorders. Two overlapping groups were selected for examination, namely, pregnancy. Data from Finnish Genetics Pre-eclampsia Consortium...

10.1001/jamacardio.2023.1312 article EN cc-by JAMA Cardiology 2023-06-07

Prioritization of compounds based on human hepatotoxicity potential is currently a key unmet need in drug discovery, as it can become major problem for several lead later stages the discovery pipeline. The authors report validation and implementation high-content multiparametric cytotoxicity assay simultaneous measurement 8 cell health indicators associated with nuclear morphology, plasma membrane integrity, mitochondrial function, proliferation. Compounds are prioritized by (a) computing an...

10.1177/1087057108318428 article EN cc-by-nc-nd SLAS DISCOVERY 2008-06-20
Nina Mars Elisabeth Widén Sini Kerminen Tuomo J Meretoja Matti Pirinen and 95 more Pietro Della Briotta Parolo Priit Palta Aki Havulinna Amanda Elliott Anastasia Shcherban Andrea Ganna Anu Jalanko Arto Lehisto Elina Kilpeläinen Georg Brein Awaisa Ghazal Hannele Laivuori Henrike Heyne Jarmo Harju Jiwoo Lee Juha Karjalainen Jukka Koskela Kalle Pärn Kati Donner Kristin Tsuo Manuel González Jiménez Mari Kaunisto Mari Niemi Mary Pat Reeve Mervi Aavikko Mitja Kurki Oluwaseun Alexander Dada Pietro Della Briotta Parolo Risto Kajanne Sina Rüeger Susanna Lemmelä Taru Tukiainen Jaakko Tuomilehto Timo P. Sipilä Tuomo Kiiskinen Vincent Llorens Adam Ziemann Anne Lehtonen Apinya Lertratanakul Bob Georgantas Bridget Riley‐Gillis Danjuma Quarless Fedik Rahimov Howard Jacob Jeffrey F. Waring J. Wade Davis Nizar Smaoui Relja Popovic Sahar Esmaeeli Athena Matakidou Ben Challis David A. Close Eleonor Wigmore Slavé Petrovski Chia‐Yen Chen Ellen Tsai Heiko Runz Jimmy Z. Liu Paola G. Bronson Sally John Sanni Lahdenperä Stephanie Loomis Susan Eaton Yunfeng Huang Erika Kvikstad Minal Çalışkan Samir Wadhawan Elmutaz Shaikho Elhaj Mohammed Janet van Adelsberg Joseph Maranville Marla Hochfeld Robert Plenge Shameek Biswas Steven M. Greenberg Andrew S. Peterson David F. Choy Diana Chang Edmond Teng Erich C. Strauss Geoff Kerchner Hao Chen Hubert Chen Jennifer L. Schutzman John A. Michon Julie Hunkapiller Mark I. McCarthy Natalie Bowers Sarah A. Pendergrass Tushar Bhangale David Pulford Dawn Waterworth Diptee Kulkarni Fanli Xu Jo Betts Jorge Esparza Gordillo

Abstract Polygenic risk scores (PRS) for breast cancer have potential to improve prediction, but there is limited information on their utility in various clinical situations. Here we show that among 122,978 women the FinnGen study with 8401 cases, PRS modifies of two high-impact frameshift variants. Similarly, after diagnosis, individuals elevated an developing contralateral cancer, and can considerably assessment female first-degree relatives. In more detail, c.1592delT variant PALB2...

10.1038/s41467-020-19966-5 article EN cc-by Nature Communications 2020-12-14
Erik L. Bao Satish K. Nandakumar Xiaotian Liao Alexander G. Bick Juha Karjalainen and 95 more Marcin Tabaka Olga I. Gan Aki S. Havulinna Tuomo Kiiskinen Caleb A. Lareau Aitzkoa Lopez de Lapuente Portilla Bo Li Connor A. Emdin Veryan Codd Christopher P. Nelson Christopher J. Walker Claire Churchhouse Albert de la Chapelle Daryl E. Klein Björn Nilsson Peter W.F. Wilson Kelly Cho Saiju Pyarajan J. Michael Gaziano Nilesh J. Samani Aarno Palotie Mark J. Daly Howard J. Jacob Athena Matakidou Heiko Runz Sally John Robert Plenge Mark I. McCarthy Julie Hunkapiller Meg Ehm Dawn Waterworth Caroline S. Fox Anders Mälarstig Kathy Klinger Kathy Call Tomi P. Mäkelä Jaakko Kaprio Petri Virolainen Kari Pulkki Terhi Kilpi Markus Perola Jukka Partanen Anne Pitkäranta Riitta Kaarteenaho Seppo Vainio Kimmo Savinainen Veli‐Matti Kosma Urho M. Kujala Outi Tuovila Minna Hendolin Raimo Pakkanen Jeff Waring Bridget Riley‐Gillis Athena Matakidou Heiko Runz Jimmy Z. Liu Shameek Biswas Julie Hunkapiller Dawn Waterworth Meg Ehm Dorothée Diogo Caroline S. Fox Anders Mälarstig Catherine Marshall Xinli Hu Kathy Call Kathy Klinger Matthias Gossel Samuli Ripatti Johanna Schleutker Markus Perola Mikko Arvas Olli Carpén Reetta Hinttala Johannes Kettunen Reijo Laaksonen Arto Mannermaa Urho M. Kujala Outi Tuovila Minna Hendolin Raimo Pakkanen Hilkka Soininen Valtteri Julkunen Anne M. Remes Reetta Kälviäinen Mikko Hiltunen Jukka Peltola Pentti J. Tienari Juha O. Rinne Adam Ziemann Jeffrey F. Waring Sahar Esmaeeli Nizar Smaoui Anne Lehtonen Susan Eaton

10.1038/s41586-020-2786-7 article EN Nature 2020-10-14

Abstract Background Alzheimer’s disease (AD) is a chronic progressive neurodegenerative impacting an estimated 44 million adults worldwide. The causal pathology of AD (accumulation amyloid-beta and tau), precedes hallmark symptoms dementia by more than decade, necessitating development early diagnostic markers onset, particularly for new drugs that aim to modify processes. To evaluate differentially methylated positions (DMPs) as novel blood-based biomarkers AD, we used subset 653...

10.1186/s13148-020-00864-y article EN cc-by Clinical Epigenetics 2020-06-15

Abstract Background Identifying biomarkers associated with Alzheimer’s disease (AD) progression may enable patient enrichment and improve clinical trial designs. Epigenome-wide association studies have revealed correlations between DNA methylation at cytosine-phosphate-guanine (CpG) sites AD pathology diagnosis. Here, we report relationships peripheral blood profiles measured using Infinium® MethylationEPIC BeadChip in participants from the Disease Neuroimaging Initiative (ADNI) cohort....

10.1186/s13148-021-01179-2 article EN cc-by Clinical Epigenetics 2021-10-15
Hanna M. Ollila Eilon Sharon Ling Lin Nasa Sinnott-Armstrong Aditya Ambati and 95 more Selina Yogeshwar Ryan P. Hillary Otto Jolanki Juliette Faraco Mali Einen Guo Luo Jing Zhang Fang Han Han Yan Xiao Song Dong Jing Li Jun Zhang Seung‐Chul Hong Tae Won Kim Yves Dauvilliers Lucie Barateau Gert Jan Lammers Rolf Fronczek Geert Mayer Joan Santamaría Isabelle Arnulf Stine Knudsen May Kristin Lyamouri Bredahl Per Medbøe Thorsby Giuseppe Plazzi Fabio Pizza Monica Moresco Catherine Crowe Stephen K. Van Den Eeden Michel Lecendreux Patrice Bourgin Takashi Kanbayashi F Martínez-Orozco Rosa Peraita‐Adrados Antonio Benetó Jacques Montplaisir Alex Désautels Yu‐Shu Huang Thomas D. Als Adam Ziemann Ali Abbasi Anne Lehtonen Apinya Lertratanakul Bridget Riley‐Gillis Fedik Rahimov Howard J. Jacob Jeffrey F. Waring Mengzhen Liu Nizar Smaoui Relja Popovic Adam Platt Athena Matakidou Benjamin Challis Dirk S. Paul Glenda Lassi Ioanna Tachmazidou Antti Hakanen Johanna Schleutker Nina Pitkänen Perttu Terho Petri Virolainen Arto Mannermaa Veli‐Matti Kosma Chia‐Yen Chen Heiko Runz Sally John Sanni Lahdenperä Stephanie Loomis Susan Eaton George Okafo Heli Salminen‐Mankonen Marc Jung Nathan Lawless Zhihao Ding Joseph Maranville Marla Hochfeld Robert Plenge Shameek Biswas Masahiro Kanai Mutaamba Maasha Wei Zhou Outi Tuovila Raimo Pakkanen Jari A. Laukkanen Teijo Kuopio Kristiina Aittomäki Antti Mäkitie Natalia Pujol Triin Laisk Katriina Aalto‐Setälä Johanna Mäkelä Marco Hautalahti Sarah Smith Tom Southerington Eeva Kangasniemi

Narcolepsy type 1 (NT1) is caused by a loss of hypocretin/orexin transmission. Risk factors include pandemic 2009 H1N1 influenza A infection and immunization with Pandemrix®. Here, we dissect disease mechanisms interactions environmental triggers in multi-ethnic sample 6,073 cases 84,856 controls. We fine-mapped GWAS signals within HLA (DQ0602, DQB1*03:01 DPB1*04:02) discovered seven novel associations (CD207, NAB1, IKZF4-ERBB3, CTSC, DENND1B, SIRPG, PRF1). Significant at TRA DQB1*06:02 loci...

10.1038/s41467-023-36120-z article EN cc-by Nature Communications 2023-05-15
Nina Mars Sini Kerminen Max Tamlander Matti Pirinen Eveliina Jakkula and 95 more Kirsimari Aaltonen Tuomo J Meretoja Sirpa Heinävaara Elisabeth Widén Samuli Ripatti Aarno Palotie Mark J. Daly Bridget Riley-Gills Howard Jacob Dirk S. Paul Athena Matakidou Adam Platt Heiko Runz Sally John George Okafo Nathan Lawless Robert M. Plenge Joseph Maranville Mark I. McCarthy Julie Hunkapiller Margaret G. Ehm Kirsi Auro Simonne Longerich Caroline S. Fox Anders Mälarstig K. Klinger Deepak Raipal Eric Green Robert Graham Robert Yang Chris O’Donnell Tomi P. Mäkelä Jaakko Kaprio Petri Virolainen Antti Hakanen Terhi Kilpi Markus Perola Jukka Partanen Anne Pitkäranta Juhani Junttila Raisa Serpi Tarja Laitinen Veli‐Matti Kosma Jari A. Laukkanen Marco Hautalahti Outi Tuovila Raimo Pakkanen Jeffrey F. Waring Bridget Riley‐Gillis Fedik Rahimov Ioanna Tachmazidou Chia‐Yen Chen Heiko Runz Zhihao Ding Marc Jung Shameek Biswas Rion Pendergrass Julie Hunkapiller Margaret G. Ehm David Pulford Neha Raghavan Adriana Huertas‐Vázquez Jae-Hoon Sul Anders Mälarstig Xinli Hu K. Klinger Robert Graham Eric Green Sahar V. Mozaffari Dawn Waterworth Nicole Renaud Ma’en Obeidat Samuli Ripatti Johanna Schleutker Markus Perola Mikko Arvas Olli Carpén Reetta Hinttala Johannes Kettunen Graham J. Mann Katriina Aalto‐Setälä Mika Kähönen Jari A. Laukkanen Johanna Mäkelä Reetta Kälviäinen Valtteri Julkunen Hilkka Soininen Anne M. Remes Mikko Hiltunen Jukka Peltola Minna Raivio Pentti Tienari Juha O. Rinne Roosa Kallionpää Juulia Partanen

PURPOSE Family history (FH) and pathogenic variants (PVs) are used for guiding risk surveillance in selected high-risk women but little is known about their impact breast cancer screening on population level. In addition, polygenic scores (PRSs) have been shown to efficiently stratify through combining information common genetic factors into one measure. METHODS longitudinal real-life data, we evaluate PRS, FH, PVs stratified screening. Using FinnGen (N = 117,252), linked the Mass Screening...

10.1200/jco.23.00295 article EN cc-by-nc-nd Journal of Clinical Oncology 2024-02-29

Protein tyrosine phosphatase 1B (PTP1B) has been implicated as a negative regulator of insulin action. Overexpression PTP1B protein observed in insulin-resistant states associated with obesity. Mice lacking functional gene exhibit increased sensitivity and are resistant to weight gain. To investigate the role adipose tissue from obese animals, hyperglycemic (ob/ob) mice were treated antisense oligonucleotide (ISIS-113715). A significant reduction adiposity correlated decrease levels fat....

10.2337/diabetes.51.8.2405 article EN Diabetes 2002-08-01

Idiosyncratic adverse drug reactions (IADRs) represent an important human health problem, yet animal models for preclinical prediction of these are lacking. Recent evidence in animals suggests that some IADRs arise from interaction with inflammatory episode renders the liver sensitive to injury. Diclofenac (DCLF) is one those drugs which clinical use limited by idiosyncratic We tested hypothesis modest inflammation triggered rats a small dose lipopolysaccharide (LPS) nonhepatotoxic DCLF...

10.1124/jpet.106.110247 article EN Journal of Pharmacology and Experimental Therapeutics 2006-09-21

Isolated primary human hepatocytes are a well accepted system for evaluating pharmacological and toxicological effects in humans. However, questions remain regarding how culturing affects the liver-specific functions of hepatocytes. In addition, cryopreservation could also potentially affect differentiation state The first aim present study was to compare gene expression freshly isolated that liver origin evaluate changes occurring after cryopreservation/thawing, both when maintained...

10.1124/dmd.105.007708 article EN Drug Metabolism and Disposition 2006-02-10

Idiosyncratic drug toxicity refers to toxic reactions occurring in a small subset of patients and usually cannot be predicted during preclinical or early phases clinical trials. One hypothesis for the pathogenesis hepatic idiosyncratic is that, certain individuals, underlying inflammation results sensitization liver, such that injury occurs from an agent typically would not cause hepatotoxicity at therapeutic dose. We explored this possibility by cotreating rats with nonhepatotoxic doses...

10.1124/jpet.105.096347 article EN Journal of Pharmacology and Experimental Therapeutics 2005-11-18

The effectiveness of IFN-alpha2b for human multiple myeloma has been variable. TRAIL proposed to mediate apoptosis in myeloma. In this study we assessed the effects signaling on apoptotic activity and cell survival. While was one most potently induced proapoptotic genes cells following treatment, less than 20% underwent apoptosis. Thus, hypothesized that an IFN-stimulated gene (ISG) with prosurvival might suppress TRAIL-mediated Consistent this, stabilized mitochondria inhibited caspase-3...

10.1172/jci31122 article EN Journal of Clinical Investigation 2007-09-07
Eliza C. Miller Anni Kauko Sarah E. Tom Hannele Laivuori Teemu Niiranen and 95 more Natalie A. Bello Aarno Palotie Mark J. Daly Bridget Riley-Gills Howard J. Jacob Dirk S. Paul Athena Matakidou Adam Platt Heiko Runz Sally John George Okafo Nathan Lawless Heli Salminen‐Mankonen Robert Plenge Joseph Maranville Mark I. McCarthy Julie Hunkapiller Margaret G. Ehm Kirsi Auro Simonne Longerich Caroline S. Fox Anders Mälarstig K. Klinger Deepak Raipal Eric Green Robert Graham Robert Yang Chris O ́Donnell Tomi P. Mäkelä Jaakko Kaprio Petri Virolainen Antti Hakanen Terhi Kilpi Markus Perola Jukka Partanen Anne Pitkäranta Taneli Raivio Raisa Serpi Tarja Laitinen Veli‐Matti Kosma Jari A. Laukkanen Marco Hautalahti Outi Tuovila Raimo Pakkanen Jeffrey F. Waring Bridget Riley‐Gillis Fedik Rahimov Ioanna Tachmazidou Chia-Yen Chen Heiko Runz Zhihao Ding Marc Jung Shameek Biswas Rion Pendergrass Julie Hunkapiller Margaret G. Ehm David Pulford Neha Raghavan Adriana Huertas‐Vázquez Jae-Hoon Sul Anders Mälarstig Xinli Hu K. Klinger Robert Graham Eric Green Sahar V. Mozaffari Dawn Waterworth Nicole Renaud Ma ́en Obeidat Samuli Ripatti Johanna Schleutker Markus Perola Mikko Arvas Olli Carpén Reetta Hinttala Johannes Kettunen Graham J. Mann Katriina Aalto‐Setälä Mika Kähönen Jari A. Laukkanen Johanna Mäkelä Reetta Kälviäinen Valtteri Julkunen Hilkka Soininen Anne M. Remes Mikko Hiltunen Jukka Peltola Minna Raivio Pentti J. Tienari Juha O. Rinne Roosa Kallionpää Juulia Partanen Ali Abbasi Adam Ziemann Nizar Smaoui

BACKGROUND: Adverse pregnancy outcomes (APO) contribute to higher risk of maternal cerebrovascular disease, but longitudinal data that include APO and stroke timing are lacking. We hypothesized associated with younger age at first stroke, a stronger relationship in those >1 APO. METHODS: analyzed Finnish nationwide health registry from the FinnGen Study. included women who gave birth after 1969 when hospital discharge was established. defined as affected by gestational hypertension,...

10.1161/strokeaha.123.043052 article EN Stroke 2023-05-22

Abstract Background Limited understanding of the diversity variants in cystic fibrosis transmembrane conductance regulator ( CFTR ) gene across ancestries hampers efforts to advance molecular diagnosis (CF). The consequences pose a risk delayed diagnoses and subsequently worsened health outcomes for patients. Therefore, characterizing spectrum is critical revolutionizing CF. Methods We analyzed 454,727 UK Biobank (UKBB) whole-exome sequences characterize ancestries. Using PanUKBB...

10.1186/s13073-024-01316-5 article EN cc-by Genome Medicine 2024-03-21
Coming Soon ...